Mahsan Rafizadeh, MD joined Acumen as a Senior Scientist in February 2022. In this role Rafizadeh supports Acumen Bioanalytical operations, bioanalytical assay development, and CSF Biomarkers analysis. Prior to joining Acumen, Rafizadeh worked at the University of California Los Angeles for 22 years as a laboratory manager in the Neurology Department and received the “Staff Achievement Award” for her outstanding performance and significant contributions. In her previous position, she focused on the role of GABAergic inhibition in steroid hormone-related disorders, such as catamenial epilepsy and postpartum depression in animal models of disease. At Acumen, she applies her extensive background in animal behavior and translational research to the field of Alzheimer’s disease. Rafizadeh obtained her medical degree in Internal Medicine from the University of Medicine and Pharmacy “Carol Davila” in Bucharest.